Tempest Therapeutics Q3 EPS $(0.79) Beats $(3.27) Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings BeatsNews
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(3.27) by 75.84 percent. This is a 85.15 percent increase over losses of $(5.32) per share
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(3.27) by 75.84 percent. This is a 85.15 percent increase over losses of $(5.32) per share from the same period last year.